Global Transcriptomics Market top key players are QIAGEN (Exiqon), Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Fluidigm Corporation, and Promega Corporation.
The Global Transcriptomics Market was valued at $3.2 billion in 2016, and is expected to reach $7.9 billion by 2023, with at a CAGR of 13.8% from 2017 to 2023. Real-time PCR segment held more than two-fifths share of the total market in 2016.
Increase in technological advancements and rise in research grants by various institutes is expected to drive the market growth. In addition, the potential of RNAs to act as candidates for diagnostic biomarkers and predictors of drug response are anticipated to further drive the demand for transcriptomics globally. However, standardization concerns over RNA sequencing and lack of skilled professionals restrict the market growth.
Download Sample Copy of this Report at: https://www.alliedmarketresearch.com/request-sample/2595
Instruments were valued at $874 million in 2016 and is estimated to reach at $2,135 million by 2023 at a CAGR of 13.5% during the forecast period. In addition, services segment is the fastest growing segment in the transcriptomics market, registering a CAGR of 16.0% during the forecast period.
Government institutes & academic centers segment is projected to maintain its lead in the overall transcriptomics market throughout the forecast period. This is primarily attributed to the increased research projects to test the ability of RNA as candidates of disease biomarkers. Furthermore, CROs is anticipated to exhibit the highest growth, with a CAGR of 14.1% during the forecast period.
Check available discounts on this report at: https://www.alliedmarketresearch.com/purchase-enquiry/2595
Transcriptomics Market Key Findings:
- Drug discovery application led the overall transcriptomics market, and accounted for nearly three-fifths of the total market in 2016.
- Sequencing technology is projected to grow at highest CAGR of 15.1% during the forecast period.
- CROs are the fastest growing end user market for transcriptomics and are expected to witness CAGR of 14.1% during the forecast period.
- qPCR technology segment occupied nearly half of the global transcriptomics market in 2016.
- Japan is the major shareholder, accounting for more than one-third of the Asia-Pacific transcriptomics market in 2016.
North America accounted for the share of more than 45% of the overall market in 2016 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increased funding for research institutes and increased incidence of chronic disorders such as cancer. However, Asia-Pacific is projected to be the fastest growing region throughout the analysis period, at a CAGR of 15.7%.
Scope Of The Report
| Report Attribute | Details |
| Market size available for years | 2017-2023 |
| Base year considered | 2018 |
| Forecast period | 2018-2023 |
| Forecast units | Value (USD) |
| Segments covered | by Technology, Products & Services, Application |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
Related Report:
Cell-based Assay Market by Product (Consumable, Instrument, Service, and Software), Application (Drug Discovery; Basic Research; Absorption, Distribution, Metabolism, & Excretion (ADME) Studies; Predictive Toxicology; and Others), and End User (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, Contract Research Organizations, and Others) – Global Opportunity Analysis and Industry Forecast, 2017-2023
Membrane Microfiltration Market by Filtration mode (Cross-flow, Direct-flow, and Others], Material (Organic, and Inorganic), and End user (Hospitals & laboratories, Pharmaceutical and biopharmaceutical companies, Food and beverage, Water & waste water treatment, and others) – Global Opportunity Analysis and Industry Forecast, 2014-2022
High-throughput Screening Market by Product & Service (Reagents & Assay Kits, Instruments, Consumables & Accessories, Software, and Services) by Technology (Cell-based Assays, 2D Cell Culture, 3D Cell Culture, Perfusion Cell Culture, Lab-on-a-chip, Ultrahigh-throughput Screening, Bioinformatics, and Label-free Technology), by Application (Target Identification & Validation, Primary & Secondary Screening, Toxicology Assessment, Others), and by End User (Pharmaceutical & Biotechnology Companies, Academic &and Government Institutes, and Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2019–2026
Protein Sequencing Market by Product and Service (Reagents & Consumables, Instruments, Analysis Products, Protein Sequencing Services, and Others), Technology (Mass Spectrometry, and Edman Degradation), Application (Biotherapeutics, Genetic Engineering), and End User (Pharmaceutical and Biotechnological Companies, Academic Institute, and Research Centers): Global Opportunity Analysis and Industry Forecast, 2018–2025
Contact:
Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com